Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cardiex.
RELATED STOCKHEAD STORIES
Health & Biotech
Suda Pharma pops 44pc on cap raise; Acrux and other biotechs whet investor appetites
Health & Biotech
CardieX launches CONNEQT to compete with consumer tech giants Apple and Fitbit
News
Last Orders: The ASX starts the week on a positive note
Health & Biotech
Check Up: Eco-fibre play Nanollose leads ASX healthcare sector with 292% gain
Health & Biotech
Check Up: Rhythm Biosciences shares just keep on soaring
Health & Biotech
Telehealth in 2021: What will change and will a COVID-19 vaccine stop the sector’s growth?
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
CardieX makes tilt for US$509 billion digital health market with major manufacturing deal
Health & Biotech
StockDoc Podcast: Blood pressure monitoring tech hasn’t changed in a 100 years, CardieX is set on changing that
Tech
Bursting the breakeven barrier — 4 ASX small caps discuss their path to profitability
Health & Biotech
How CardieX is disrupting the last legacy health sector
Health & Biotech
How tech is changing healthcare, and where professional ASX investors are looking
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Lunchtime ASX small cap wrap: Who’s in the throes of capitulation today?
News